Enlivex Invests $212 Million in RAIN Tokens, Signaling Major Shift Toward Crypto in Finance

Nasdaq-listed Enlivex Therapeutics has taken a bold step toward mainstream crypto adoption with a massive investment of $212 million in RAIN tokens. This landmark move signifies growing confidence from institutional investors in cryptocurrency and marks a significant shift towards digital asset use in corporate finance. 💰 💻 Enlivex’s strategic decision to allocate this capital exclusively to RAIN tokens signals their vision for a modern financial infrastructure where cryptocurrencies play a vital role, moving beyond traditional assets.